The aim of the study is to elucidate, if the colonization of bacteria is lower on the Novosyn® CHD suture compared to uncoated Polyglactin 910 suture, which will be assessed by the incidence of surgical site infections (SSI: A1 and A2). The results of this registry will generate further clinical evidence for the use and the benefit of a Chlorhexidine coated suture used to close the wound after an emergency or elective laparoscopic or laparotomy surgery. The benefit for individual patients lies in the early diagnosis of complications and in the optimized postoperative controls of a clinical study.
Patients undergoing an emergency or elective laparotomy or laparoscopic surgery.
Written informed consent
Age≥ 18 years
Not incapacitated patient
No exclusion criteria except patients with allergy or hypersensitivity to chlorhexidine
Aesculap AG
Lead sponsor
B.Braun Surgical SA
Collaborator